Relay Therapeutics Inc (RLAY)

SG&A Expenses

$14.69M

Quarterly · Period ending: · USD

RLAY logo

RLAY SG&A Expenses

Latest reported$14.69M
RLAY Quarterly SG&A Expenses ($3.07M → $14.69M)
High-resolution chart · PNG

RLAY sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Relay Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
14,691,000
11,027,000
12,963,000
12,502,000
13,752,000
18,739,000
20,552,000
19,750,000
20,139,000
19,799,000
20,397,000
18,485,000
20,120,000
19,579,000
19,721,000
16,074,000
17,465,000
16,068,000
15,474,000
15,501,000
14,422,000
12,735,000
15,339,000
12,231,000
6,053,000
4,758,000
3,426,000
3,652,000
3,508,000
3,067,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.